These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10706191)

  • 1. Predictability of the effects of race or ethnicity on pharmacokinetics of drugs.
    Johnson JA
    Int J Clin Pharmacol Ther; 2000 Feb; 38(2):53-60. PubMed ID: 10706191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of race or ethnicity on pharmacokinetics of drugs.
    Johnson JA
    J Pharm Sci; 1997 Dec; 86(12):1328-33. PubMed ID: 9423140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
    Chen ML
    Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction.
    Shen DD; Kunze KL; Thummel KE
    Adv Drug Deliv Rev; 1997 Sep; 27(2-3):99-127. PubMed ID: 10837554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999.
    Evelyn B; Toigo T; Banks D; Pohl D; Gray K; Robins B; Ernat J
    J Natl Med Assoc; 2001 Dec; 93(12 Suppl):18S-24S. PubMed ID: 11798060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.
    Morgan DJ; McLean AJ
    Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of sex on pharmacokinetics.
    Schwartz JB
    Clin Pharmacokinet; 2003; 42(2):107-21. PubMed ID: 12537512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics.
    Huang Z; Ung T
    Curr Drug Metab; 2013 Feb; 14(2):226-38. PubMed ID: 23092311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach.
    Davies NM; Skjodt NM
    Clin Pharmacokinet; 2000 May; 38(5):377-92. PubMed ID: 10843458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review and assessment of potential sources of ethnic differences in drug responsiveness.
    Bjornsson TD; Wagner JA; Donahue SR; Harper D; Karim A; Khouri MS; Murphy WR; Roman K; Schneck D; Sonnichsen DS; Stalker DJ; Wise SD; Dombey S; Loew C
    J Clin Pharmacol; 2003 Sep; 43(9):943-67. PubMed ID: 12971027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered pharmacokinetics of a novel anticancer drug, UCN-01, caused by specific high affinity binding to alpha1-acid glycoprotein in humans.
    Fuse E; Tanii H; Takai K; Asanome K; Kurata N; Kobayashi H; Kuwabara T; Kobayashi S; Sugiyama Y
    Cancer Res; 1999 Mar; 59(5):1054-60. PubMed ID: 10070963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs.
    Mehvar R; Brocks DR; Vakily M
    Clin Pharmacokinet; 2002; 41(8):533-58. PubMed ID: 12102640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.
    Bannwarth B; Péhourcq F; Schaeverbeke T; Dehais J
    Clin Pharmacokinet; 1996 Mar; 30(3):194-210. PubMed ID: 8882301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saturable pharmacokinetics in the renal excretion of drugs.
    van Ginneken CA; Russel FG
    Clin Pharmacokinet; 1989 Jan; 16(1):38-54. PubMed ID: 2650954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics in the elderly.
    Crooks J; O'Malley K; Stevenson IH
    Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consideration of sheep as a minor species: comparison of drug metabolism and disposition with other domestic ruminants.
    Short CR
    Vet Hum Toxicol; 1993; 35 Suppl 2():40-56. PubMed ID: 8236767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of pharmacokinetic models of hepatic elimination.
    Morgan DJ; Smallwood RA
    Clin Pharmacokinet; 1990 Jan; 18(1):61-76. PubMed ID: 2178850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonlinear pharmacokinetics: clinical Implications.
    Ludden TM
    Clin Pharmacokinet; 1991 Jun; 20(6):429-46. PubMed ID: 2044328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.